China grants first Covid-19 vaccine patent to CanSino: Report


Source: deccanherald.com deccanherald.com

Key Topics in this News Article:

News Snapshot:

China's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its Covid-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country's intellectual property regulator. It is the first Covid-19 vaccine patent granted by China, state-owned newspaper People's Daily reported on Sunday. For latest updates and live news on coronavirus, click here The paper cited documents published by China's National Intellectual Property Administration saying that the patent was issued on August 11. Saudi Arabia said this month it plans to begin Phase III clinical trials for the CanSino vaccine. CanSino has said it is also...